Crinetics Pharmaceuticals Competitors and Similar CompaniesClear all

Crinetics Pharmaceuticals's competitors and similar companies include Immatics, Pharming Group, Alexion Pharmaceuticals and Macopharma.

	Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.	Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	Macopharma Macopharma is a provider of blood transfusion and bio-sourced therapies.
Founding Date	Founding Date 2008	Founding Date N/A	Founding Date 1988	Founding Date 1992	Founding Date 1977
Type	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations San Diego, US HQ	Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US	Locations Leiden, NL HQ Leiden, NL	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations Tourcoing, FR HQ Mouvaux, FR
Employees	Employees 43751% increase	Employees 29723% increase	Employees 404	Employees 10,6006% increase	Employees 901
Valuation ($)	Valuation ($) 5.1 b	Valuation ($) 1.1 b	Valuation ($) 590.3 m	Valuation ($) 40.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $7.7m (FY, 2025)	Revenue (est.) €48.3m (FY, 2025)	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) N/A
Cost of goods	Cost of goods $1.1m (FY, 2025)	Cost of goods N/A	Cost of goods $41.6m (FY, 2025)	Cost of goods $553.5m (FY, 2020)	Cost of goods N/A
Gross profit	Gross profit $6.6m (FY, 2025)	Gross profit €53m (FY, 2025)	Gross profit $341m (FY, 2025)	Gross profit $5.5b (FY, 2020)	Gross profit N/A
Net income	Net income ($465.3m) (FY, 2025)	Net income (€196.4m) (FY, 2025)	Net income $2.5m (FY, 2025)	Net income $603.4m (FY, 2020)	Net income N/A
Funding
Total funding raised	Total funding raised $ 41.5m	Total funding raised $ 267.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Immatics

Tübingen, DE

Employees

297↑ 23% increase

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.

View company

Pharming Group

Leiden, NL

Employees

404

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.

View company

Alexion Pharmaceuticals

Boston, US

Employees

10,600↑ 6% increase

Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.